CANADA LIFE ASSURANCE Co Sells 3,798 Shares of Exponent, Inc. (NASDAQ:EXPO)

CANADA LIFE ASSURANCE Co lessened its holdings in Exponent, Inc. (NASDAQ:EXPO) by 8.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,875 shares of the business services provider’s stock after selling 3,798 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings in Exponent were worth $3,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Ontario Teachers Pension Plan Board raised its holdings in shares of Exponent by 77.4% in the 4th quarter. Ontario Teachers Pension Plan Board now owns 30,727 shares of the business services provider’s stock worth $2,738,000 after purchasing an additional 13,406 shares during the period. Barclays PLC lifted its position in shares of Exponent by 88.5% during the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider’s stock valued at $16,209,000 after buying an additional 85,395 shares during the last quarter. Townsquare Capital LLC grew its stake in shares of Exponent by 11.8% during the 4th quarter. Townsquare Capital LLC now owns 29,049 shares of the business services provider’s stock worth $2,588,000 after acquiring an additional 3,068 shares during the period. Redwood Park Advisors LLC purchased a new stake in Exponent in the 4th quarter worth about $201,000. Finally, Abacus FCF Advisors LLC raised its stake in Exponent by 46.4% in the 4th quarter. Abacus FCF Advisors LLC now owns 23,460 shares of the business services provider’s stock valued at $2,090,000 after acquiring an additional 7,440 shares during the period. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Stock Up 0.2 %

Shares of NASDAQ:EXPO opened at $79.15 on Friday. The firm has a market capitalization of $4.02 billion, a PE ratio of 37.34 and a beta of 0.84. The company has a 50-day moving average price of $81.36 and a two-hundred day moving average price of $91.03. Exponent, Inc. has a twelve month low of $73.83 and a twelve month high of $115.75.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period last year, the business posted $0.41 earnings per share. Analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Insider Activity

In other Exponent news, VP Richard Reiss sold 1,736 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is owned by company insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.